Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Cells, Tissues, Organs|November 12, 2002
Gene therapy for sarcomaS Fruehauf, M R Veldwijk, S Berlinghoff, et al.ESMO Real World Data and Digital Oncology|February 6, 2026
Changes in survival of >3800 patients with metastatic colorectal cancer in Germany: results from a 16-year prospective longitudinal real-world data analysisN Marschner, T Seufferlein, K Potthoff, et al.Toxicology Letters|November 18, 2017
Development of MS Binding Assays targeting the binding site of MB327 at the nicotinic acetylcholine receptorS Sichler, G Höfner, S Rappenglück, et al.Journal of the American Veterinary Medical Association|November 3, 2006
Effect of certified health programs on the sale price of beef calves marketed through a livestock videotape auction service from 1995 through 2005Michael E King, M D Salman, Thomas E Wittum, et al.Clinical and Vaccine Immunology : CVI|July 26, 2013
Flow cytometric detection of Mycobacterium avium subsp. paratuberculosis-specific antibodies in experimentally infected and naturally exposed calvesS Schillinger, P S Bridger, H Bulun, et al.Toxicology|February 22, 2012
Restoration of soman-blocked neuromuscular transmission in human and rat muscle by the bispyridinium non-oxime MB327 in vitroT Seeger, M Eichhorn, M Lindner, et al.Bone Marrow Transplantation|June 21, 2006
Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functionsF A Giordano, B Fehse, A Hotz-Wagenblatt, et al.ESMO Open|July 12, 2024
Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trialA Ballhausen, M Karthaus, S Fruehauf, et al.ESMO Open|July 13, 2023
Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212)K Heinrich, M Karthaus, S Fruehauf, et al.BMC Cancer|July 27, 2022
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancerG Sommerhäuser, A Kurreck, S Stintzing, et al.Pageof 10